16-67675448-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030819.4(GFOD2):c.865G>A(p.Ala289Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000459 in 1,612,392 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030819.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GFOD2 | NM_030819.4 | c.865G>A | p.Ala289Thr | missense_variant | 3/3 | ENST00000268797.12 | NP_110446.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GFOD2 | ENST00000268797.12 | c.865G>A | p.Ala289Thr | missense_variant | 3/3 | 1 | NM_030819.4 | ENSP00000268797.7 | ||
GFOD2 | ENST00000602377 | c.*543G>A | 3_prime_UTR_variant | 3/3 | 4 | ENSP00000477784.1 | ||||
GFOD2 | ENST00000602522.1 | n.2037G>A | non_coding_transcript_exon_variant | 1/1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000361 AC: 9AN: 249188Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135084
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1460030Hom.: 0 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 726462
GnomAD4 genome AF: 0.000112 AC: 17AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74502
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The c.865G>A (p.A289T) alteration is located in exon 3 (coding exon 2) of the GFOD2 gene. This alteration results from a G to A substitution at nucleotide position 865, causing the alanine (A) at amino acid position 289 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at